Peter A. Everts։ Platelet Phenotype May Hold the Key to More Consistent PRP Therapy
Peter A. Everts, Senior Director Medical Affairs at Bioventus, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Clinical Medicine, adding:
”We are excited to share our new review in the Journal of Clinical Medicine: ‘Are Platelet Volume, Density, and the Homeostatic Blueprint the Missing Link in Platelet-Rich Plasma Therapies?’
PRP is used in orthopedics and sports medicine on a daily basis, yet outcomes stay inconsistent.
We argue that the field has focused heavily on platelet dosing, and not as much on PRP bioformulations and platelet phenotypes.
Larger, denser, younger platelets carry far more granular content, factors that actually drive repair.
Our recommendation: measure platelet indices (MPV, PDW, density) before preparing PRP, and use protocols that recover these denser, more reactive platelets—rather than treating platelet density as a fixed value.
We present this as a grounded hypothesis: the mechanistic links are well supported, but proving that high-MPV enrichment improves outcomes awaits prospective trials. That’s the work we hope this prompts.”
Title: Are Platelet Volume, Density, and the Homeostatic Blueprint the Missing Link in Platelet-Rich Plasma Therapies? An Evidence-Based Narrative Review
Authors: Peter A. Everts, Luga Podesta, Jane Fitzpatrick, Leonardo P. Oliveira, José Fábio Lana, André van Zundert, Mikel Sánchez, Diego Delgado, Christine Brown Mahoney, Glenn Flanagan, Robert Alexander, Paul Harrison
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 18, 2026, 15:25Brandon Temple: Turning Personal Experience Into Advocacy for wAIHA Research
-
Sep 18, 2026, 15:01A. M. Thirugnanam: Antiplatelet Discontinuation and the Risk of Stent Thrombosis
-
Sep 18, 2026, 14:52Abdul Muqtadir Abbasi: How Do Hematologists Know Which Coagulation Factor Is the Problem?
-
Sep 18, 2026, 14:48Kato Ramaekers: Redefining Integrin αIIbβ3 in Platelet Formation
-
Sep 18, 2026, 14:33Heghine Khachatryan: The discussion of Thrombophilia, APS and Coagulation Testing
-
Sep 18, 2026, 14:27Maria Cherska: Are We Overlooking the Spleen in Cardiometabolic Research?
-
Sep 18, 2026, 14:05Wolfram Ruf: Managing Thrombotic Risk in Pregnancy
-
Sep 18, 2026, 13:38Sam Tsimikas: Uncovering a Modifiable Lp(a) Phenotype in Hypertriglyceridemia
-
Sep 18, 2026, 13:22Christine Rabinak: Predictive Modeling for Individualized Unfractionated Heparin Dosing